Nuvilex Eyes FDA Fast Track After ABRAXANE Approved for Pancreatic Cancer
September 11, 2013 08:45 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Sep 11, 2013) - Nuvilex, Inc. (OTCQB: NVLX) and its shareholders enjoyed what could be a dress rehearsal of their own future with the Food and Drug Administration's...